A total of 4876 households were selected for textile durability assessment over the four cross-sectional surveys between 07th January 2020 and 10th February 2022. Of these, 67% (n = 3284) consented to participate in the study. From the consenting households, 5817 children were tested for malaria infection, and 5060 study LLINs (1464 PY-LLIN, 1500 Chlorfenapyr-PY LLIN, 1181 Pyriproxyfen-PY LLIN, and 915 PBO-PY LLIN) were assessed for fabric integrity. At baseline (October 2018), malaria prevalence measured in children aged 6 months to 14 years was 44% (1948/4403), balanced across study arms.8, 20
Ownership of any net (at least 1 net per household) remained high over the study period, from 99.7% 3 months after net distribution to 96.2% (1036/1077) at t36. Ownership of study net (≥ 1 study LLIN per house) declined over the three years of the study from a high of 92% (697/755 houses) after t12 in January 2020 to 62% (672/1077) in January 2022 (Table 1). Reported study net use recorded during cross-sectional surveys also declined over the three years of the study from 72% (3155/4373) three months after the mass distribution in January 20198 to 23% (2068/9044) in January 2022 at t36 (Table 1). The lowest study net use was in the PBO-PY group at the t36 timepoint (19% (286/1469)). Between t30 and t36, the ownership of other PBO-PY LLIN in the study area (in all arms) increased from 13% (229/1723) to 33% (1076/3263) due to the local government-led top-up campaigns through the School Net program (SNP) (Additional file 6).
Table 1
Household, socioeconomic, and net characteristics of participating households in the cross-sectional surveys
Covariates | Cross-sectional survey |
Cross-sectional survey timepoint | 12 months | 24 months | 30 months | 36 months |
Mean number of people per household (sd), N | 7.1 (3.0), 755 | 8.1 (3.4), 803 | 8.0 (3.6), 649 | 8.4 (3.8), 1077 |
Mean number of children (< 15 years) per household (sd), N * | 3.6 (1.9), 755 | 4.2 (2.1), 803 | 4.0 (2.2), 649 | 4.2 (2.2), 1077 |
Mean number of sleeping spaces used last night (sd), N | 2.9 (1.4), 755 | 3.2 (1.6), 803 | 3.2 (1.5), 649 | 3.5 (1.7), 1077 |
Households characteristics: | | | | |
% electricity (95%CI), N | 24.5 (21.6–27.7) | 27.3 (24.3–30.5) | 36.1 (32.5–39.8) | 37.7 (34.9–40.6) |
% open eaves: (95%CI), N | 32.1 (28.8–35.5) | 34.1 (30.9–37.5) | 34.9 (31.4–38.7) | 31.57 (28.9–34.4) |
Main housing materials | | | | |
% floor: earth/sand (95%CI), N | 64.8 (61.3–68.1) | 67.6 (64.3–70.8) | 58.6 (54.7–62.3) | 61.8 (58.8–64.6) |
% roof: tin (95%CI), N | 71.9 (68.6–75.0) | 72.7 (69.5–75.7) | 77.2 (73.8–80.3) | 74.5 (71.8–77.0) |
% walls: unburnt bricks or mud (95%CI), N | 79.3 (76.3–82.1) | 78.5 (75.5–81.2) | 76.4 (73.0-79.5) | 76.9 (74.3–79.3) |
% no ceiling (95%CI), N | 97.5 (96.1–98.4) | 97.9 (96.6–98.7) | 96.5 (94.7–97.6) | 96.8 (95.5–97.7) |
% plastered walls | 67.3 (63.9–70.5) | 63.0 (59.6–66.3) | 67.5 (63.8–71.0) | 67.3 (64.5–70.1) |
Mean number of mosquito nets owned per household (sd), N | | | | |
Any LLIN | 3.8 (1.8), 755 | 3.1 (1.6), 803 | 2.7 (1.6), 649 | 3.0 (1.8), 1077 |
Study LLIN | 2.5 (1.5), 755 | 1.6 (1.2), 803 | 1.2 (1.1), 649 | 1.1 (1.1), 1077 |
Mean number of nets used last night per household (sd), N | | | | |
Any LLIN | 2.4 (1.3), 755 | 2.4 (1.3), 803 | 2.0 (1.3), 649 | 2.3 (1.5), 1077 |
Study LLIN | 1.6 (1.2), 755 | 1.2 (1.1), 803 | 0.9 (1.0), 649 | 0.8 (0.9), 1077 |
Proportion of households with at least 1 net % (n/N) | | | | |
Any LLIN | 100 (755/755) | 98.5 (791/803) | 95.5 (620/649) | 96.2 (1036/1077) |
Study LLIN | 92.3 (697/755) | 78.3 (629/803) | 66.6 (432/649) | 62.4 (672/1077) |
Proportion of participants reporting using a net the night before % (n/N) | | | |
Any LLIN | 81.3 (4306/5294) | 75.4 (4899/6502) | 62.3 (3220/5170) | 67.8 (6128/9041) |
Study LLIN | 51.6 (2805/5435) | 37.4 (2432/6502) | 27.8 (1439/5171) | 22.9 (2068/9044) |
Varieties of nets available in the household | N = 3010 | N = 2513 | N = 1723 | N = 3263 |
% Pyrethroid (PY) LLIN (n) | 16.5 (498) | 14.0 (352) | 14.2 (245) | 11.3 (369) |
% Chlorfenapyr-PY LLIN (n) | 18.5 (557) | 13.7 (345) | 12.6 (217) | 11.7 (318) |
% PBO-PY LLIN (n) | 13.4 (403) | 8.6 (215) | 8.1 (139) | 4.8 (158) |
% Pyriproxyfen-PY LLIN (n) | 15.2 (458) | 13.0 (327) | 10.3 (178) | 6.7 (218) |
% Permanet 2.0 (n) | 17.4 (525) | 19.2 (482) | 20.3 (349) | 16.6 (543) |
% Olyset net (n) | 13.9 (419) | 23.8 (597) | 18.6 (312) | 13.7 (447) |
% Olyset Plus (distributed by NMCP) (n) | 0.3 (9) | 6.37 (160) | 13.3 (229) | 33.0 (1076) |
% Others nets (n) | 1.3 (141) | 0.6 (35) | 1.2 (45) | 1.0 (71) |
Number of children tested for malaria (n/N) | 1275/1374 | 1476/1534 | 1146/1227 | 1920/2026 |
% Malaria infection in 6 months-14 years children (95%CI) | 18.7 (16.6–20.9) | 38.4 (35.9–40.9) | 45.6 (42.7–48.5) | 31.1 (29.1–33.2) |
sd: standard deviation; CI: confidence intervals; N: total number of observations, NMCP: National Malaria Control Program |
In the nets collected during cross-sectional surveys, overall, at t12, 54% (597/1110) of the study nets had at least one hole of any size (53% (152/285)-pyrethroid (PY) LLIN, 48% (162/341)-Chlorfenapyr-PY LLIN, 52% (125/241)-Pyriproxyfen-PY LLIN, and 65% (158/243)-PBO-PY LLIN), and this increased to 82% (830/1007) (84% (274/326)-PY-LLIN, 81% (280/346)-Chlorfenapyr-PY LLIN, 81% (162/200)-Pyriproxyfen-PY LLIN and 84% (114/135)-PBO-PY LLIN) at t36. Similarly, the mean Hole Surface Area (HSA) increased from 340 cm² to 1242 cm² in Pyrethroid-PY, 355 cm² to 1325 cm² in Chlorfenapyr-PY LLIN, 526 cm² to 1301 cm² in Pyriproxyfen-PY LLIN and 990 cm² to 2060 cm² in PBO-PY LLIN between t12 and t36 (Additional file 3). There were no significant differences in mean HSA between PY-LLIN, Chlorfenapyr-PY LLIN, and Pyriproxyfen-PY LLIN at any survey time point, while PBO-PY LLIN had substantially higher HSA at each time point than any other study net (Additional file 3). The overall percentage of extremely torn nets in the cross-sectional surveys increased from 17% (189/1110) at t12 to 35% (372/1055) at t24 and stabilised between 44% (311/700) at t30 and 43% (432/575) at t36 (Additional file 2). In all net brands, the lower part of the nets (bottom zone) was more damaged than the rest of the zones (Additional file 4). All new nets had similar dimensions (height: 180cm); however, after three years of field use, the height decreased disproportionately between net brands to 170cm for PY-LLIN, 174 cm for Chlorfenapyr-PY LLIN, 157cm for Pyriproxyfen-PY LLIN, and 158cm for PBO-PY LLIN (Additional file 5).
There was no significant association between malaria prevalence and net condition: damaged (OR: 0.98, 95%CI: 0.71–1.37, p-value = 0.6550) and too-torn (OR: 1.07, 95%CI: 0.77–1.47, p-value = 0.6940) compared to good nets (Table 2; Additional file 10). Malaria infection was also significantly lower for children living in clusters that received Chlorfenapyr-PY LLINs compared to those living in clusters that received PY LLINs regardless of the physical condition (Table 2). Children from houses with more than 50% of the sleeping spaces covered by the study nets had lower odds of malaria (OR: 0.61, 95%CI: 0.42–0.87, p-value = 0.006) than households with fewer sleeping spaces covered. The odds of malaria in all arms increased with time since the net distribution, however, was lower at t36 compared to t24, and this was likely related to the distribution of PBO-PY LLIN in all arms in October 2021 (four months before t36 survey) in the study area via the school-net program (SNP). Moreover, children sleeping under nets had lower odds of malaria infection than children not using any nets (Additional file 7). In the surveyed households, the majority of households reported closing the main doors at night, getting inside houses, and sleeping time between 21h and 22h (Additional file 9).
Table 2
Association between net physical condition and malaria prevalence in children aged 6 months to 14 years
Covariate | %Infection (n/N) | Adjusted OR | 95% CI | p-value |
Net condition | | | | |
Good | 24.6 (180/733) | 1 (Ref) | | |
Damaged | 25.4 (109/429) | 0.98 | 0.71–1.37 | 0.6550 |
Too-torn | 28.3 (146/516) | 1.07 | 0.77–1.47 | 0.6940 |
Study arm | | | | |
Pyrethroid (PY) LLIN | 33.7 (168/498) | 1 (Ref) | | |
Chlorfenapyr-PY LLIN | 17.7 (90/508) | 0.40 | 0.23–0.69 | 0.001 |
Pyriproxyfen-PY LLIN | 28.4 (101/356) | 0.80 | 0.47–1.38 | 0.430 |
PBO-PY LLIN | 24.1 (76/316) | 0.62 | 0.35–1.08 | 0.091 |
Cross-sectional survey | | | | |
12 months post-intervention | 17.0 (103/607) | 1 (Ref) | | |
24 months post-intervention | 36.1 (210/582) | 2.93 | 2.15–3.99 | < 0.001 |
36 months post-intervention | 25.0 (122/489) | 1.72 | 1.22–2.43 | 0.002 |
Children age | | | | |
0–4 years | 14.8 (97/656) | 1 (Ref) | | |
5–10 years | 30.5 (213/699) | 2.86 | 2.13–3.85 | < 0.001 |
11–14 years | 38.7 (125/323) | 4.62 | 3.25–6.58 | < 0.001 |
SES | | | | |
Lowest | 27.5 (156/567) | 1 (Ref) | | |
Middle | 27.2 (155/571) | 0.92 | 0.68–1.26 | 0.622 |
Highest | 23.0 (124/540) | 0.66 | 0.46–0.93 | 0.018 |
Eaves | | | | |
Yes | 30.7 (167/544) | 1 (Ref) | | |
No | 23.6 (268/1134) | 0.78 | 0.59–1.04 | 0.096 |
Household study net coverage* | | | | |
Too few (< 50%) | 45.6 (800) | 1 (Ref) | | |
Moderate/high ( > = 50%) | 27.4 (1775) | 0.61 | 0.42–0.87 | 0.006 |
*Household study net coverage: is the proportion of sleeping spaces in the household used last night covered by study net; There was no evidence of interaction between net physical condition and net type, p-value = 0.9814. There was no evidence of interaction between net type and survey timepoint, p-value = 0.5010.
In the cohort, 5019 children (2256 in year 1 and 2763 in year 2) were assessed alongside the study nets they used at the last cohort visit. Of these children, 2239 (99%) in year 1 and 2403 (87%) in year 2 declared to own study nets. These nets were brought for physical condition assessment. Overall, the mean HSA in the cohort nets was 786 cm² for year 1 and 1047 cm² for year 2. Over the two years of cohort study, the overall percentage of extremely torn nets increased from 19% (430/2234) at t12 to 33% (801/2397) at t24 (Additional file 2).
There were increased rates of malaria cases in children sleeping under too-torn nets (IRR 1.33 [95% CI 1.12–1.57], p = 0.0012) compared to sleeping under good nets (Table 3). Lower rates of malaria cases were associated with living in houses with the highest social-economic status (IRR 0·77 [95% CI 0.63–0.96], p = 0.0189), using Chlorfenapyr-PY LLIN (IRR 0·49 [95% CI 0.31–0.79], p = 0·0035). Higher rates were associated with using study nets that were two years old (IRR 1·41 [95% CI 1.19–1.67], p = 0.0001). Older children and living in a house with open eaves were not associated with a higher incidence of malaria.
Table 3
Association between net physical condition and malaria case incidence in children aged 6 months to 10 years
Covariate | Number of clinical episodes | Follow-up time child years | Incidence per child per year | | Adjusted Rate ratio | 95%CI | p-value |
Study net condition | | | | | | | |
Good | 573 | 2268.4 | 0.25 | | 1 (ref) | | |
Damaged | 258 | 902.9 | 0.29 | | 1.18 | 0.97–1.43 | 0.0936 |
Too-torn | 379 | 1184.7 | 0.32 | | 1.33 | 1.12–1.57 | 0.0012 |
Study arm | | | | | | | |
Pyrethroid (PY) LLIN | 392 | 1114.7 | 0.35 | | 1 (ref) | | |
Chlorfenapyr-PY LLIN | 174 | 1120.4 | 0.16 | | 0.49 | 0.31–0.79 | 0.0035 |
Pyriproxyfen-PY LLIN | 363 | 1124.4 | 0.32 | | 1.00 | 0.64–1.58 | 0.9844 |
PBO-PY LLIN | 281 | 996.5 | 0.28 | | 0.83 | 0.52–1.32 | 0.4334 |
Cohort year | | | | | | | |
year1 | 434 | 1931.4 | 0.22 | | 1 (ref) | | |
year2 | 776 | 2424.6 | 0.32 | | 1.41 | 1.19–1.67 | 0.0001 |
Children age group | | | | | | | |
0–4 years | 512 | 1879.7 | 0.27 | | 1 (ref) | | |
5–10 years | 698 | 2476.3 | 0.28 | | 1.08 | 0.92–1.27 | 0.3604 |
Socio-economic status | | | | | | |
Lowest | 296 | 899.6 | 0.33 | | 1 (ref) | | |
Middle | 273 | 897.2 | 0.30 | | 0.96 | 0.79–1.16 | 0.6542 |
Highest | 217 | 874.0 | 0.25 | | 0.77 | 0.63–0.96 | 0.0189 |
Eaves | | | | | | | |
No | 829 | 3061.1 | 0.27 | | 1 (ref) | | |
Yes | 381 | 1294.8 | 0.29 | | 1.00 | 0.82–1.21 | 0.9768 |
In order to assess if the dual-AI LLINs were superior to PY LLINs against incidence regardless of their textile conditions, we compared each net type and condition to a PY LLIN in good condition. During the first year of follow-up, the protective effect of extremely-torn dual-AI LLINs compared to good (HSA: ≤ 79 cm2) PY LLIN against malaria case incidence was strongest for (HSA: > 789 cm2) PBO-PY LLIN (IRR 0·37 [95% CI 0·19 − 0·72], p = 0·0033), borderline for chlorfenapyr-PY LLIN (IRR: 0·45 [95% CI 0·33 − 0·97], p = 0·0525) and no additional protection was given by pyriproxyfen-PY LLIN (IRR 1·15 [95% CI 0·61 − 2·17], p = 0·6596). Sleeping under a good PBO-PY LLIN or a good chlorfenapyr-PY LLIN was more protective than sleeping under a good PY LLIN against malaria case incidence. For children using pyriproxyfen-PY LLIN, however, there was a slight decrease in malaria incidence in children sleeping under damaged nets (0.26 cases per child/year) or good nets (0.24 cases per child/year); however, those differences were not significant compared to good PY LLIN (IRR = 0.74 [95% 0.38–1.46], p = 0.3856) -for damaged pyriproxyfen-PY LLIN and (IRR = 0.78 [95% 0.46–1.34], p = 0.3688) for good pyriproxyfen-PY LLIN (Table 4a).
Table 4
a: Association between net physical condition and malaria case incidence in children aged 6 months to 10 years in year 1
LLIN type and condition | Number of clinical episodes | Follow-up time child years | Incidence per child per year | Adjusted Rate ratio | 95%CI | p-value |
Pyrethroid (PY) LLIN | | | | | | |
Good | 104 | 313.48 | 0.33 | 1 | | |
Damaged | 36 | 95.67 | 0.38 | 0.90 | 0.57–1.43 | 0.6538 |
Too-torn | 30 | 81.17 | 0.37 | 0.93 | 0.56–1.54 | 0.7778 |
Pyriproxyfen-PY LLIN | | | | | | |
Good | 83 | 342.67 | 0.24 | 0.78 | 0.46–1.34 | 0.3688 |
Damaged | 22 | 84.64 | 0.26 | 0.74 | 0.38–1.46 | 0.3856 |
Too-torn | 34 | 84.41 | 0.40 | 1.15 | 0.61–2.17 | 0.6596 |
PBO-PY LLIN | | | | | | |
Good | 33 | 199.70 | 0.17 | 0.43 | 0.23–0.80 | 0.0076 |
Damaged | 12 | 70.58 | 0.17 | 0.61 | 0.28–1.33 | 0.2128 |
Too-torn | 22 | 174.74 | 0.13 | 0.37 | 0.19–0.72 | 0.0033 |
Chlorfenapyr-PY LLIN | | | | | | |
Good | 34 | 309.56 | 0.11 | 0.35 | 0.28–0.71 | 0.0006 |
Damaged | 15 | 96.40 | 0.16 | 0.51 | 0.38–1.03 | 0.0675 |
Too-torn | 10 | 79.30 | 0.13 | 0.45 | 0.33–0.97 | 0.0525 |
In year 2, compared to those sleeping under good PY-LLIN, only children sleeping under chlorfenapyr-PY LLIN in good condition had a significant and more substantial protective effect (IRR = 0.49 [95% CI 0.52–1.37], p = 0.0059) against malaria case incidence (Table 4b). There was no reduced risk of infection associated with sleeping under too-torn PBO-PY LLIN (IRR = 1.36 [95% 0.86–2.16], p = 0.1858) and too-torn Pyriproxyfen-PY LLIN (IRR = 1.46 [95% CI 0.89–2.37], p = 0.1305) in year 2 compared to PY-LLIN in good condition.
Table 4
b: Association between net physical condition and malaria case incidence in children aged 6 months to 10 years in year 2
LLIN type and condition | Number of clinical episodes | Follow-up time child years | Incidence per child per year | Rate ratio | 95%CI | p-value |
Pyrethroid (PY) LLIN | | | | | | |
Good | 107 | 312.18 | 0.34 | 1 | | |
Damaged | 62 | 159.22 | 0.39 | 1.19 | 0.83–1.70 | 0.3533 |
Too-torn | 53 | 152.95 | 0.35 | 1.07 | 0.74–1.56 | 0.7125 |
Pyriproxyfen-PY LLIN | | | | | | |
Good | 80 | 299.81 | 0.27 | 0.85 | 0.52–1.37 | 0.4949 |
Damaged | 57 | 133.47 | 0.43 | 1.37 | 0.82–2.28 | 0.2308 |
Too-torn | 87 | 179.46 | 0.48 | 1.46 | 0.89–2.37 | 0.1305 |
PBO-PY LLIN | | | | | | |
Good | 67 | 181.21 | 0.37 | 1.18 | 0.72–1.94 | 0.5144 |
Damaged | 26 | 91.19 | 0.29 | 0.98 | 0.54–1.77 | 0.9505 |
Too-torn | 119 | 275.63 | 0.43 | 1.36 | 0.86–2.16 | 0.1858 |
Chlorfenapyr-PY LLIN | | | | | | |
Good | 50 | 317.19 | 0.16 | 0.49 | 0.29–0.81 | 0.0059 |
Damaged | 36 | 169.21 | 0.21 | 0.67 | 0.39–1.16 | 0.1499 |
Too-torn | 30 | 153.87 | 0.19 | 0.64 | 0.36–1.14 | 0.1286 |